21 hrs ago | The Jersey Journal
Continue reading "Profit falls 21 percent for ImClone in second quarter"
Biotechnology company ImClone Systems today said its second-quarter profit fell almost 21 percent as rising research and development costs offset royalties and other payments from its only marketed drug, ...
Yesterday | Bloomberg
Lilly, Bristol-Myers Profits Gain on Psychiatric Drug Sales, Weaker Dollar
Eli Lilly & Co. 's profit jumped 44 percent and Bristol-Myers Squibb Co. earnings rose 23 percent, boosted by sales of psychiatric medicines and the weak dollar.
Microsoft the winner in Yahoo-Icahn pact?
Updated 10:45 a.m. PDT, with comments from the M&A director of research at RiskMetrics Group.
The Latest on Sam Waksal - ImClone's Founder
For cancer patients, any word of the possible release down the road of Sam Waksal is likely to be celebrated.
ERBITUX (Cetuximab) Receives Approval In Japan For Use In Advanced Colorectal Cancer
ImClone Systems Incorporated , a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that ERBITUX has received marketing authorization in Japan for use in ...
ImClone Systems Incorporated - SWOT Analysis - www.companiesandmarkets.com adds new report
The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Biotech Stocks: Drug stocks hug flat line, Abbott edges higher
Drug stocks traded largely flat Wednesday morning while shares of Abbott Laboratories edged higher in the wake of a positive second-quarter earnings report.
Executive Moves: ImClone Systems
Mr. Bailey has accepted a senior level commercial position with Synta Pharmaceuticals , a New England-based biopharmaceutical company.
Synta Pharma adds ImClone exec to executive team
Synta Pharmaceuticals Corp. , a biopharmaceutical company focused on developing chemical-based, or small-molecule, drugs for cancer and other diseases, has appointed Michael Bailey as senior vice president and ...
ImClone's Sam Waksal Returning to New York
He's five years into a seven-year insider-trading sentence at the federal prison in Milan, Michigan, but they say he'll be out in August.
Young Cancer Patients Get New Bikes And An Evening Of Fun
The Kids Cancer Foundation of South Florida and ImClone Systems Inc., a national oncology pharmaceutical company, held a Family Fun Event on Friday, June 27 at Okeeheelee Park for local kids with cancer.
5 Stocks Approaching Greatness
Some companies are obviously great investments -- in hindsight. Sure, we should have bought Starbucks at its IPO and earned huge returns over the years.
Analyst initiations: North American pipeline sector, ARO and IMCL
MOST NOTEWORTHY: The North American Pipeline sector, Aeropostale and ImClone were today's noteworthy initiations: OTHER INITIATIONS: When you enter your name and email address, you'll be sent a link to confirm ...
IMC-A12 Plus Temsirolimus Clinical Trial For Advanced Cancer Opens For Patient Enrollment
Main Category: Cancer / Oncology Also Included In: Clinical Trials / Drug Trials Article Date: 27 Jun 2008 ImClone Systems Incorporated , a global leader in the development and commercialization of novel ...
Change in Reporting Relationship Entitles Ex-President/CEO to Severance Payments
A trial judge in New York recently granted plaintiff C. Richard Stafford summary judgment, holding that his former employer breached his employment contract by failing to make severance payments.
Martha Stewart denied visa to travel to Britain
Celebrity homemaker Martha Stewart has been denied entry to Britain because of her 2004 U.S. conviction for lying about a stock sale.
Live From Bio: Activist Investors
Fool contributor and health-care sector editor Brian Orelli is hanging out at the Bio International Convention this week.
Martha Stewart Living Chief Lyne Steps Down; Millard, Marino to Take Over
Millard had been president of the media division and Marino had headed merchandising, Martha Stewart Living said in a statement today.
Cancer drug works as initial treatment, ImClone says
CHICAGO : Two biotechnology giants did battle here at the largest U.S. cancer conference over the weekend.
Bristol-Myers, ImClone, Genentech Release Promising Data at ASCO
BMY / DNA / IMCL One of the pharmaceutical industry's biggest and most high profile society conferences is the American Society of Clinical Oncology, or ASCO, meeting.